MEI Pharma Inc (MEIP) — Cash Flow Quality Index

Latest as of September 2023: -0.33x

MEI Pharma Inc (MEIP) has a Cash Flow Quality Index of -0.33x as of September 2023. Operating cash flow of $-18.49 Million is below net income of $56.37 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore MEI Pharma Inc total assets for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.33x
Operating CF / Net Income

Operating Cash Flow

$-18.49 Million
USD

Net Income

$56.37 Million
USD

Data as of

Sep 2023
Most recent filing

MEI Pharma Inc Cash Flow Quality Index (2017–2024)

Historical Cash Flow Quality Index for MEI Pharma Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of MEI Pharma Inc to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for MEI Pharma Inc (2017–2024)

Year-by-year earnings quality comparison for MEI Pharma Inc. For live market cap and the full company financial profile, see market cap of MEI Pharma Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2024 -2.84x $-50.47 Million $17.78 Million ▼ -317.5%
2017 1.31x $3.49 Million $2.67 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.